DK2865376T4 - Klæbende præparatsammensætning opnået ved hjælp af blanding af lægemiddel, organisk opløsningsmiddel, lipofil salvebasis og pulver - Google Patents

Klæbende præparatsammensætning opnået ved hjælp af blanding af lægemiddel, organisk opløsningsmiddel, lipofil salvebasis og pulver Download PDF

Info

Publication number
DK2865376T4
DK2865376T4 DK13806076.9T DK13806076T DK2865376T4 DK 2865376 T4 DK2865376 T4 DK 2865376T4 DK 13806076 T DK13806076 T DK 13806076T DK 2865376 T4 DK2865376 T4 DK 2865376T4
Authority
DK
Denmark
Prior art keywords
lipofilic
drug
powder
mixture
organic solvent
Prior art date
Application number
DK13806076.9T
Other languages
English (en)
Other versions
DK2865376T3 (da
Inventor
Hidetoshi Hamamoto
Katsuhiro Yamanaka
Takahiro Tanimoto
Original Assignee
Medrx Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49768781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2865376(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medrx Co Ltd filed Critical Medrx Co Ltd
Publication of DK2865376T3 publication Critical patent/DK2865376T3/da
Application granted granted Critical
Publication of DK2865376T4 publication Critical patent/DK2865376T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK13806076.9T 2012-06-20 2013-06-18 Klæbende præparatsammensætning opnået ved hjælp af blanding af lægemiddel, organisk opløsningsmiddel, lipofil salvebasis og pulver DK2865376T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012139215 2012-06-20
PCT/JP2013/066765 WO2013191187A1 (ja) 2012-06-20 2013-06-18 薬剤と有機溶媒と親油性膏体基剤と粉体を配合した貼付製剤組成物

Publications (2)

Publication Number Publication Date
DK2865376T3 DK2865376T3 (da) 2019-08-12
DK2865376T4 true DK2865376T4 (da) 2022-07-18

Family

ID=49768781

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13806076.9T DK2865376T4 (da) 2012-06-20 2013-06-18 Klæbende præparatsammensætning opnået ved hjælp af blanding af lægemiddel, organisk opløsningsmiddel, lipofil salvebasis og pulver

Country Status (16)

Country Link
US (2) US10543275B2 (da)
EP (1) EP2865376B2 (da)
JP (1) JP6309892B2 (da)
CN (3) CN110693859A (da)
AU (1) AU2013278403B2 (da)
BR (1) BR112014031701A2 (da)
CA (1) CA2875454C (da)
DK (1) DK2865376T4 (da)
ES (1) ES2738303T5 (da)
HU (1) HUE045479T2 (da)
IN (1) IN2014DN10706A (da)
PL (1) PL2865376T5 (da)
PT (1) PT2865376T (da)
SI (1) SI2865376T1 (da)
TR (1) TR201911328T4 (da)
WO (1) WO2013191187A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9980920B2 (en) * 2013-09-11 2018-05-29 Medrx Co., Ltd. Base composition for tape agent
CN103830206B (zh) * 2014-02-26 2016-08-31 上海现代药物制剂工程研究中心有限公司 阿戈美拉汀三维网状立体构型的透皮给药制剂及制备方法
MX2016011152A (es) * 2014-02-27 2016-12-09 Medrx Co Ltd Parche transdermico que contiene pramipexol para tratamiento de enfermedad neurodegenerativa.
US20160184246A1 (en) * 2014-12-30 2016-06-30 Noven Pharmaceuticals, Inc. Transdermal drug delivery systems for agomelatine
CN107427509B (zh) * 2015-08-29 2021-06-15 美德阿利克斯株式会社 含有碱性药物和山梨酸的经皮吸收组成物
WO2017037812A1 (ja) * 2015-08-29 2017-03-09 株式会社メドレックス 酸捕捉剤を含有する貼付製剤
US10016502B2 (en) 2015-08-29 2018-07-10 Medrx Co., Ltd Patch preparation containing an acid scavenger
US20170273974A1 (en) 2016-03-24 2017-09-28 Medrx Co., Ltd Patch preparations with misuse prevention features
EP3434267B1 (en) * 2016-03-24 2023-07-26 MEDRx Co., Ltd. Patch preparation having misuse prevention characteristics
EP3540023A4 (en) * 2016-11-09 2020-06-17 Kuraray Co., Ltd. ADHESIVE FILM, TAPE PLASTER AND METHOD FOR THE PRODUCTION THEREOF
CN113164423A (zh) * 2018-10-04 2021-07-23 美德阿利克斯株式会社 用非水溶剂稳定化的制剂
JP7179212B1 (ja) * 2022-05-02 2022-11-28 久光製薬株式会社 リドカイン含有貼付剤

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3144895B2 (ja) * 1992-06-30 2001-03-12 積水化学工業株式会社 医療用粘着テープもしくはシート
JPH06145050A (ja) 1992-11-11 1994-05-24 Sekisui Chem Co Ltd 貼付剤の製造方法
JPH07145047A (ja) * 1993-11-25 1995-06-06 Sekisui Chem Co Ltd 局所麻酔用経皮吸収テープ
JPH0827003A (ja) † 1994-07-22 1996-01-30 Sekisui Chem Co Ltd 経皮吸収製剤
JPH09169636A (ja) * 1995-06-12 1997-06-30 Sekisui Chem Co Ltd 貼付剤
JPH09136834A (ja) * 1995-11-14 1997-05-27 Sekisui Chem Co Ltd 経皮吸収貼付剤
JP4648518B2 (ja) * 2000-06-01 2011-03-09 帝國製薬株式会社 ４−ビフェニル酢酸含有貼付剤
DE10033853A1 (de) † 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
US6503532B1 (en) * 2001-04-13 2003-01-07 Murty Pharmaceuticals, Inc. Pharmaceutical composition containing tetrahydrocannabinol and a transdermal/transcutaneous delivery method thereof
JP4758101B2 (ja) * 2002-09-13 2011-08-24 久光製薬株式会社 貼付剤
EP1591110B1 (en) * 2003-01-22 2015-03-18 Senju Pharmaceutical Co., Ltd. Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye
US8080261B2 (en) * 2004-09-30 2011-12-20 Teikoku Pharma Usa, Inc. 1-chloro-2,4-dinitrobenzene non-aqueous gel compositions and methods for using the same
US20090317452A1 (en) 2006-09-11 2009-12-24 Sekisui Chemical Co. Td. Transdermal patch
WO2008032718A1 (fr) * 2006-09-11 2008-03-20 Sekisui Chemical Co., Ltd. Préparation adhésive
JP5333972B2 (ja) * 2007-11-22 2013-11-06 株式会社 メドレックス 脂肪酸系イオン液体を有効成分とする外用剤組成物
US20110189261A1 (en) 2008-03-03 2011-08-04 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
JP4822032B2 (ja) 2009-01-08 2011-11-24 タイヨーエレック株式会社 組合せ式遊技機
WO2010113225A1 (en) * 2009-03-30 2010-10-07 Yutoku Pharmaceutical Industries Co., Ltd. Riluzole-containing transdermal patch
DE102009022915A1 (de) * 2009-05-27 2010-12-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit gesteuertem Wirkstofffluss
JP2011074035A (ja) 2009-09-30 2011-04-14 Sekisui Medical Co Ltd 貼付剤

Also Published As

Publication number Publication date
AU2013278403B2 (en) 2018-02-01
CA2875454A1 (en) 2013-12-27
CA2875454C (en) 2021-02-16
WO2013191187A1 (ja) 2013-12-27
CN108553452A (zh) 2018-09-21
DK2865376T3 (da) 2019-08-12
IN2014DN10706A (da) 2015-09-04
BR112014031701A2 (pt) 2017-06-27
US20150174249A1 (en) 2015-06-25
US12016924B2 (en) 2024-06-25
CN110693859A (zh) 2020-01-17
PL2865376T5 (pl) 2023-01-09
EP2865376A1 (en) 2015-04-29
EP2865376B2 (en) 2022-05-11
EP2865376A4 (en) 2015-11-18
JPWO2013191187A1 (ja) 2016-05-26
PT2865376T (pt) 2019-08-26
US10543275B2 (en) 2020-01-28
HUE045479T2 (hu) 2019-12-30
PL2865376T3 (pl) 2019-12-31
SI2865376T1 (sl) 2019-11-29
CN104363900A (zh) 2015-02-18
EP2865376B1 (en) 2019-06-05
US20190388544A1 (en) 2019-12-26
ES2738303T3 (es) 2020-01-21
TR201911328T4 (tr) 2019-08-21
AU2013278403A1 (en) 2015-01-22
ES2738303T5 (es) 2022-09-12
JP6309892B2 (ja) 2018-04-11

Similar Documents

Publication Publication Date Title
DK2865376T4 (da) Klæbende præparatsammensætning opnået ved hjælp af blanding af lægemiddel, organisk opløsningsmiddel, lipofil salvebasis og pulver
DK3156056T3 (da) Farmaceutiske sammensætninger der består af sorbitanestere
DK3384925T3 (da) Præparat til behandling af hyperlipidæmi omfattende et oxyntomodulinderivat
DK2854514T3 (da) Udvalg af symbiota ved screening af multiple vært-symbiont-associationer
DK2673262T3 (da) Fremgangsmåder til fremstilling af quinolinforbindelser og farmaceutiske sammensætninger indeholdende sådanne forbindelser
DK2818482T3 (da) Farmaceutisk sammensætning til behandling af cancer
DK2824114T3 (da) Farmaceutisk sammensætning til behandling af cancer
DK2814849T3 (da) Fremgangsmåde til fremstilling af cyclodextrin-derivater
DK2768796T3 (da) Fremgangsmåde til fremstilling af quinolin-derivater
DK2845843T3 (da) Fremgangsmåde til fremstilling af lette, keramiske materialer
EP3035947A4 (en) A novel composition of curcumin with enhanced bioavailability
DK3210978T3 (da) Fremgangsmåde til fremstilling af acesulfamkalium
GB2507298B (en) Improved reproducibility of impact-based ionization source for low and high organic mobile phase compositions using a mesh target
BR112013019287A2 (pt) composição inovadora de pesticidas
DK2819648T3 (da) Farmaceutisk præparat omfattende et antiviralt virksomt dihydroquinazolinderivat
DK3409686T3 (da) Sammensætning omfattende en blanding af cd95-fc-isoformer
DK2925338T3 (da) Frysetørret formulering af tat-nr2b9c
HK1226392A1 (zh) 呋喃-2，5-二甲醇和(四氫呋喃-2，5-二基)二甲醇的磺酸酯及其衍生物
DK2931313T3 (da) Opløsningsformuleringer af manipulerede anti-il-23p19-antistoffer
DK2858989T3 (da) Amorf form af en AKT-hæmmende pyrimidinyl-cyclopentan-forbindelse, sammensætninger deraf og fremgangsmåder dertil
EP2991618B8 (en) Stable high strength pharmaceutical composition of levoleucovorin
BR112016029510A2 (pt) métodos para a preparação de um composto, e, composto intermediário.
DK2705847T3 (da) Sammensætning til behandling af psoriasis
DK2542555T3 (da) Fremgangsmåde til fremstilling af pyripyropenderivater
DK2561890T3 (da) Fremgangsmåde til fremstilling af medikamenter til bekæmpelse af tumorer